0001214659-20-000663.txt : 20200129 0001214659-20-000663.hdr.sgml : 20200129 20200129163017 ACCESSION NUMBER: 0001214659-20-000663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200128 FILED AS OF DATE: 20200129 DATE AS OF CHANGE: 20200129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Durrant Cameron CENTRAL INDEX KEY: 0001421882 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 20558535 MAIL ADDRESS: STREET 1: 90, FAIRMOUNT ROAD WEST CITY: CALIFON STATE: NJ ZIP: 07830-3330 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-47580.xml PRIMARY DOCUMENT X0306 4 2020-01-28 0001293310 HUMANIGEN, INC HGEN 0001421882 Durrant Cameron C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 true true false false Chief Executive Officer Stock Option (Right to Buy) 0.40 2020-01-28 4 A false 318103 0.40 A 2020-01-28 2030-01-27 Common Stock 318103 318103 D These stock options were granted in lieu of a portion of the cash bonus payable to Dr. Durrant in respect of his services as Chief Executive Officer in 2019. /s/ Cameron Durrant 2020-01-29